Together, these findings suggest that the MYCN-ATF4 axis, in cooperation with epigenetic regulators, including KDM4C, is a major mechanism to increase the pools of amino acids for sustaining the MYCN-mediated growth program in neuroblastoma [80,82]. Here, MYCN is linked to neuroblastoma.